News highlights

Stay informed with the latest news, discoveries, and developments from DIOSynVax. Explore how we’re advancing vaccine innovation to tackle global health challenges.

July 2026

The AI Discovery Awards are a core part of Nebius’ commitment to supporting startups develop AI apps in healthcare and life sciences.

June 2026

New vaccine technology created with the help of AI could provide immunity against whole families of viruses and protect from any future mutations.

June 2026

AI has been used to develop a “fundamentally new” type of vaccine that could protect against large swathes of viruses and prevent pandemics.

May 2026

Scientists race for vaccine as Ebola ravages Congo

Researchers warn funding cuts have left the country vulnerable to the deadly virus and say a vaccine is potentially just months away.

June 2025

Our Next-Generation Influenza vaccines have now demonstrated efficacy and safety in animal models and are ready for human trials.

April 2025

This bilateral project is supported by Innovate UK and Enterprise Singapore, as part of the UK-Singapore Collaborative R&D Call.

March 2025

This innovative technology aims to protect against a wide array of influenza strains.

January 2025

Driving the clinical development of its NextGen Influenza Vaccines invluding Bird-Flu.

October 2024

Insights from DIOSynVax CSO Jonathan Heeney at the World Vaccine Congress.

October 2024

We are thrilled to announce the appointment of Ron Moss as our new Chief Executive Officer.

March 2024

ProBioGen proudly announces a partnership with DIOSynVax Ltd to manufacture DIOS-HFVac3.

September 2023

Cambridge scientists hopeful that jab could also protect against future diseases.

September 2023

Studies show that just one antigen can be modified to provide a broadly protective immune response in animals.

April 2023

The vaccine has been developed by Professor Jonathan Heeney at the University of Cambridge and spin-out company DIOSynVax.

June 2022

Ambitious research project already underway aims to stamp out such viruses entirely.

April 2022

Cambridge start-up searches for next Covid jab in animal faeces.

March 2022

The Coalition for Epidemic Preparedness Innovations has pledged up to $42m to support.

March 2022

WHO consultation on COVID vaccines research: Why do we need a pan-sarbecovirus vaccine?

March 2022

The Secretary of State for Health and Social Care spoke at the summit on Tuesday 8 March 2022.

March 2022

A UK-made vaccine to protect people against future pandemics has received global backing.

February 2022

Covid vaccines: the race for a single shot to prevent new pandemics.

December 2021

A trial has begun of a new needle-free Covid-19 vaccine to protect against variants of the virus.

August 2021

COVID: we spoke to experts designing a single vaccine to defeat them all.

February 2021

A coronavirus vaccine being developed will aim to “take care of” future variants of the virus.

November 2020

DIOSynVAX CEO Jonathan Heeney is interviewed about Pfizer’s recent vaccine announcement.

September 2020

Jonathan Heeney discusses what has been learned about how Coronavirus attacks.

Learn more about our VAP design process